Literature DB >> 32665279

Neurofibromatosis-associated pulmonary hypertension: an ominous duo.

Sónia Gomes Coelho1, Maria José Loureiro2.   

Abstract

The authors report a rare clinical case of a patient with neurofibromatosis type 1 (NF1) complicated by pulmonary hypertension (PH), which presents with rapid progression. An exhaustive investigation was performed to identify the main aetiology of the PH. It was concluded that the PH could be associated with NF1, and so belonged in group 5 of the clinical classification of PH. In general, such patients have a poor long-term prognosis due to the inexistence of proven, effective treatment. Further studies are needed to better understand the mechanisms of NF1-associated PH. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  genetics; pulmonary hypertension

Mesh:

Substances:

Year:  2020        PMID: 32665279      PMCID: PMC7359064          DOI: 10.1136/bcr-2020-234976

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Pulmonary hypertension in patients with neurofibromatosis type I.

Authors:  David Montani; Florence Coulet; Barbara Girerd; Mélanie Eyries; Emmanuel Bergot; Hervé Mal; Giuseppina Biondi; Claire Dromer; Thomas Hugues; Charles Marquette; Caroline O'Connell; Dermot S O'Callaghan; Laurent Savale; Xavier Jaïs; Peter Dorfmüller; Hugues Begueret; Laurent Bertoletti; Olivier Sitbon; Christine Bellanné-Chantelot; Gérard Zalcman; Gérald Simonneau; Marc Humbert; Florent Soubrier
Journal:  Medicine (Baltimore)       Date:  2011-05       Impact factor: 1.889

2.  Pulmonary arterial hypertension in von Recklinghausen's disease.

Authors:  Forum Kamdar; Thenappan Thenappan; Emil Missov
Journal:  Am J Med       Date:  2015-07-02       Impact factor: 4.965

3.  The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes.

Authors:  M M Daston; H Scrable; M Nordlund; A K Sturbaum; L M Nissen; N Ratner
Journal:  Neuron       Date:  1992-03       Impact factor: 17.173

Review 4.  Pulmonary hypertension associated with neurofibromatosis type 1.

Authors:  Etienne-Marie Jutant; Barbara Girerd; Xavier Jaïs; Laurent Savale; Caroline O'Connell; Frederic Perros; Olivier Sitbon; Marc Humbert; David Montani
Journal:  Eur Respir Rev       Date:  2018-08-29

Review 5.  Pulmonary complications of type 1 neurofibromatosis.

Authors:  L Reviron-Rabec; B Girerd; A Seferian; K Campbell; S Brosseau; E Bergot; M Humbert; G Zalcman; D Montani
Journal:  Rev Mal Respir       Date:  2016-02-08       Impact factor: 0.622

6.  von Recklinghausen disease complicated by pulmonary hypertension.

Authors:  Y Aoki; M Kodama; T Mezaki; R Ogawa; M Sato; M Okabe; Y Aizawa
Journal:  Chest       Date:  2001-05       Impact factor: 9.410

7.  Type 1 neurofibromatosis complicated by pulmonary artery hypertension: a case report.

Authors:  Sara Simeoni; Antonio Puccetti; Marco Chilosi; Elisa Tinazzi; Daniele Prati; Roberto Corrocher; Claudio Lunardi
Journal:  J Med Invest       Date:  2007-08

8.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

Review 9.  Neurofibromatosis type 1: a multidisciplinary approach to care.

Authors:  Angela C Hirbe; David H Gutmann
Journal:  Lancet Neurol       Date:  2014-08       Impact factor: 44.182

10.  Pulmonary arterial hypertension associated with neurofibromatosis type 1.

Authors:  Miguel F Carrascosa; Isabel Celemín Larroque; Juan-Luis García Rivero; José-Antonio Saiz-Quevedo García; Marta Cano Hoz; Miguel Ares Ares; Xabier Arrastio López; José-Ramón Salcines Caviedes
Journal:  BMJ Case Rep       Date:  2010-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.